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ABSTRACT
EFFECTS OF ESTROGEN ON DORSAL ROOT GANGLION NEURONS
Sheila A. Scoville
Eastern Virginia Medical School and Old Dominion University, 1997
D irector Francis J. Liuzzi, Ph. D.

Skin sensation is mediated by dorsal root ganglion (DRG) neurons. Data
indicates that skin sensitivity in female rats is estrogen-dependent. Some DRG neurons
have estrogen receptors (ERs) which are regulated by estrogen. In these cells, nerve
growth factor (NGF) and estrogen receptors colocalize. Regulation o f NGF receptors
and neuronal sensitivity to NGF may allow estrogen to regulate NGF-dependent genes.
The goals o f the present study were to determine which DRG neurons express the ER
gene and to analyze the effects o f long-term estrogen administration on the interrelated
expression o f tyrosine kinase A (trkA), preprotachykinin (PPT), and 68kD neurofilament
(NF) genes and to compare warm thermal withdrawal latencies in these animals. The
hypothesis tested by the current study was that estrogen upregulates trkA and by doing
so, increases the sensitivity o f NGF-receptive neurons to the growth factor.
Three groups o f ovariectomized (OVX) Sprague-Dawley rats were used: OVX
(no replacement), IX (taw dose) and

10X (high dose).

The replacement groups

received daily Premarin injections. Rats from each group were killed at 56 or 90 days
and their lumbar DRGs harvested.
ER mRNA localization was done by in situ hybridization. Results showed that
ER mRNA was o f taw abundance, but was evident in smaller neurons. Quantification
revealed that both trkA and PPT mRNA was downregulated in both estrogen
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replacement groups at both time points when compared to the OVX group. TrkA
mRNA was localized predominantly in small DRG neurons. PPT mRNA was restricted
to small neurons. Estrogen treatment slowed warm thermal plantar withdrawal, but not
significantly. Neurofilament mRNA levels were dramatically increased by 56 days of
estrogen treatment in a dose-dependent manner in all size populations o f DRG neurons.
Ninety days o f estrogen treatment had a similar effect.
These data indicate that estrogen regulates DRG neuronal gene expression. An
overlapping population o f DRG neurons express the ER, trkA and PPT genes. Estrogen
may regulate the trkA and PPT genes by altering NGF sensitivity.

Since the ER gene

does not appear to be expressed by all DRG neurons, the effect o f estrogen on
neurofilament gene expression must involve alternative mechanisms.
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INTRODUCTION
BACKGROUND
According to US Census figures, by the year 2000 around 18.5 million women
will be peri-menopausal and another 30 million women will be in their post-menopausal
years (U.S. Census Bureau, 1995). Considering that the median age for menopause is
around 50 years o f age, and that the life expectancy for women is now 78, one can
expect that more than a third o f the female life span will be spent in the post-menopausal
state (Judd, et al., 1983), that is, without cyclical naturally circulating estrogen.
Although the role o f estrogen in reproduction is comparatively well understood, its
broader effects on non-reproductive organs are only now being discovered.

Effects o f Estrogen Throughout the Body
The presence o f estrogen receptors in the ovaries, endometrium, vaginal
epithelium, pituitary, urinary tract and skin (Utian, 1989) is well documented.
Additionally, estrogen receptors have been shown in vascular epithelium (Buonassisi and
Colburn, 1980) and in liver (Wrange, et al., 1980).
Other organs, such as heart and bone, are affected by estrogen, although specific
receptors have not yet been identified in these organs (Utian, 1989).

Intermediate

mechanisms affecting serum lipids are believed to be the mode o f action by which the
heart is affected (Hazzard, 1989).

Bone may also be affected by an intermediate

mechanism. In this case, estrogen is believed to regulate interleukin-6 which supresses
the action of osteoclasts (Jilka, et al, 1992).

The journal model used for this dissertation was the Journal of Neuroscience.
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Early studies o f the CNS have shown estrogen receptive neurons within the
hypothalamus and limbic system (Pfaff and Keiner, 1973), regions typically associated
with sexual behaviors. However, more recent studies suggest that estrogen receptive
neurons are more widely distributed in the CNS, in regions not primarily involved in
reproductive behavior. Not only are there ERs in the hypothalamus, they are also
expressed by some neurons within the hippocampus, (Bettini, et al., 1992) cerebral
cortex and intralaminar nuclei o f the thalamus (Simeriy, et al, 1990).

In a recent report,

Toran-Allerand and her colleagues (1992) have demonstrated estrogen receptive neurons
in the basal forebrains o f neonatal female rats and adult female mice. Nuclei containing
these neurons include the medial septum, the vertical and the horizontal limbs o f the
diagonal band, the substantia inominata, and the nucleus basalis of Meynert. More
interestingly, the estrogen receptors in these regions co-localize with low-affinity NGF
receptors (p75). These investigators concluded that their data suggest that estrogen and
NGF might act synergistically upon these neurons (Toran-Allerand, 1992).
To determine whether ER expression is a general feature o f NGF receptive
neurons, Toran-Allerand and her colleagues (Sohrabji, et al., 1994) extended their
studies to the dorsal root ganglion (DRG) neurons o f adult female rats. They reported
that all DRG neurons o f the female rat express ER mRNA.

Another laboratory,

employing different investigative methods, (Sarajari et al, 1995, and Sarajari and
Oblinger, 1996)

has reported finding estrogen receptors only within smaller DRG

neurons.
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The Effects o f Aging on Somatic Sensation
Menopause, the cessation o f estrogen production by the ovaries, is characteristic
o f normal female aging. Moreover, there is ample evidence showing an age-related
decline in peripheral nervous system function. However, relatively little attention has
been paid to gender differences in this decline. The ability to make light touch
discriminations, as measured by von Frey hairs, is decreased in elderly populations on
the palms and thumbs and on the cornea (Kenshalo, 1979). Gender was not a parameter
in these studies.

Falls and consequent fractures have a high morbidity in the

elderly. They may, in part, result from a loss or decline in proprioception. Increased
sway, indicative o f proprioceptive disturbance, is more severe in elderly females than in
elderly males (Overstall, et al., 1977).
It is well established that pain and thermal thresholds increase dramatically with
age (Tucker, et al., 1989), yet the hormonal influences on these changes have not been
explored. As early as 1931, Critchley described in a clinical study, an age-related loss o f
vibratory sensitivity in the feet, as well as, loss o f ankle jerk. Dyck and his colleagues
(1993), more recently, showed a significant increase in the vibratory detection thresholds
(VDTs) for the index finger with age. They further state that there are significant
differences with age and a significant gender difference. Females o f all ages have lower
VDTs than age-matched males. Whether hormonal status has any role in the decline of
vibratory sense was beyond the scope o f these studies.
Vibratory sense is mediated by large diameter, myelinated A0 axons (Martin,
198S). The diminution in vibratory sense and reflexes in humans may, in part, be related
to slowing o f nerve conduction velocities (NCVs) with age (Wagman and Lesse, 1952).
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NCVs are determined by two axonal characteristics, axon diameter and degree o f
myelinization. Hoffman and his colleagues (1987) have provided convincing evidence
that these interrelated features are determined by the density o f neurofilaments within
axons. This density is determined by neurofilament gene expression and synthesis.

(A

more extensive review o f the neurofilament literature is included towards the end o f the
introduction.)

Anything that decreases neurofilament gene expression would decrease

axon diameter and thereby decrease conduction velocity and myelin thickness.
Sharma and his colleagues (1980) identified some reduction in fiber size o f the rat
tibial and medial plantar nerves in male rats from 2 through 24 months o f age. Since 24
months was the extern o f this study, it is not known what further reduction in axon
diameter might have been observed after this time. Similar age-dependent reductions in
axon diameters have been reported for humans.

Tohgi and his colleagues (1977)

reported that the number o f nerve fibers in the sural nerve decrease with age, with a
greater change in larger diameter axons. While one interpretation would be that there is
a reduction o f the number o f fibers, it might also represent a gradual reduction o f the
axon diameters as well as a loss o f DRG neurons. As with many other studies o f agerelated changes in peripheral nerve, gender differences were not examined nor was
hormonal status considered.
While both aging men and women suffer these peripheral nerve sensory deficits,
little research has been done to specifically address the sensory changes brought on by
menopause. Several problems come to mind. Many investigators specifically choose
male animals for their subjects in order to remove the experimental variable o f changing
hormonal levels due to the menstrual or estrous cycle. As Berkley points out in her 1992
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paper, in a survey o f prominent neuroscience journals, 45% o f articles in recent peer
reviewed journals failed to report the gender o f the experimental subjects. Even less
likely to have been studied are the differences between cycling and non-cycling females.
The research reported in the following studies provides intriguing evidence for a link
between menopause and declining somatosensory function in aging females.

Behavioral Evidence o f Estrogen’s Effect on Somatosensory Function
It is possible to trace a few threads o f evidence from the past. In a human
experiment conducted 65 years ago, women were measured on their ability to make
two-point tactile discriminations during presumed different times o f their menstrual
cycle (Herren, 1933).

Although this study documented sensitivity changes due to “the

follicular hormone”, it attributed the mechanism of change to upper motor neuron
inhibition mediated by the sympathetic nervous system.

This study was conducted

before estrogen had been identified as a discrete entity.
One o f the first well-documented studies implicating the connection between
estrogen and sensation was reported 35 years ago. This study dealt with hormonal
effects on the brood patch o f the female canary (Hinde and Steele, 1964). Avian nesting
behavior is associated with changes to a patch of skin on the breast.
becomes more sensitive and defeathers in advance o f egg-laying.

This region

It was found that

exogenous administration o f estrogen alone could induce an increase in sensitivity, while
progesterone was found to be exclusively responsible for defeathering.
From 1972-1980, renewed interest in the topic produced three studies which
demonstrated an increase in the cutaneous sensitivity o f female rats which corresponded
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to reproductive accessibility by the males.

In the first o f the studies, genital skin was

shown to be more sensitive at proestrous, the phase o f the rat reproductive cycle with
the highest circulating estrogen

(Komisurak, 1972).

Increased skin sensitivity in

response to changes in circulating estrogen proved to be a much more generalized
phenomenon than had been suggested by the earlier investigation.

Skin from other

portions o f the rat also showed increased sensitivity during proestrus (Kow and Pfaff,
1979). A third study added several other important pieces o f information. In that study
by Bereiter and Barker (1980), receptive fields o f the skin o f rats were measured. At
proestrus, electrophysiological measurements showed that the receptive fields of skin
surface expanded an average o f 22%.

Furthermore, by cutting the dorsal roots, their

procedure allowed them to rule out the possibility o f CNS involvement, thus assuring
that the phenomenon is a peripheral one.
Since the time o f those studies, a great deal has been learned about DRG
neurons, their gene expression and function. This new knowledge may provide the basis
for an understanding o f estrogen’s role in modulating cutaneous sensation.
Morphologists have traditionally described the DRG neurons as either “small dark” or
“large light” (Lawson, 1979) and describe their axons by diameter and degree o f
myelination (Martin, 1985). More recent schemes describe DRG neurons in terms of
their transmitters o r neuropeptide content.

For example, subpopulations of DRG

neurons have been identified immuno-histochemically by their calcitonin gene-related
peptide (CGRP) or Substance P content (Verge et al 1989b). Very recently, Wright and
Snider (1995) categorized DRG neurons by the type o f neurotrophin receptors they
expressed. Still others have subdivided and characterized these sensory neurons by their
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sensory receptor type, such as the Pacinian corpuscle or the free nerve ending.
Physiologists, based on conduction velocities and patterns o f electrical activity, have
categorized these cells into 22 types (Snider, personal communication).
From a behavioral point o f view, somatic sensations are described as pain,
thermal sensations o f heat and cold, light touch, discriminative touch, vibration and
proprioception. The field o f psychophysics seeks to document sensations and changes
in these sensations through batteries o f sensory testing. The von Frey test, for example,
documents tactile sensitivity by applying a series o f hairs in graded diameters.
All o f these methods o f characterizing DRG sensory neurons have begun to
provide a broad understanding o f primary sensory neurons and the sensations subserved
by them. A new challenge, however, is to begin to understand the role o f estrogen, and
potentially other hormones, in the regulation of DRG neuronal gene expression, function
and, ultimately, cutaneous sensation.

Regulation o f DRG Neuronal Gene Expression and Function bv NGF
Since the characterization o f NGF by Levi-Montalcini (reviewed by Bendiner,
1992), scientists have sought to understand the role o f the neurotrophic molecule and its
relatives in neuronal development, maintenance and function. To date, NGF is known to
be important developmentally for the survival o f neural crest-derived neurons.
Furthermore, it is known to promote neurite outgrowth in tissue culture (Grafstein and
McQuarrie, 1978) and support the survival of axotomized sensory neurons in the adult
(Rich, et al., 1987). NGF regulates the production o f neurofilaments in NGF-dependent
DRG neurons (Verge, et al., 1990) as well as the neuropeptides, CGRP and substance P
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in those cells (Lindsay and Harmar, 1989). Additionally, the receptors for NGF, high
affinity (trkA) and low affinity (p75) have been characterized (reviewed by Chao, 1992).
About 40% o f DRG neurons bind NGF and express the high affinity NGF (trkA)
receptor gene (Verge, et al., 1989a). These neurons also express the low affinity NGF
receptor (p75). However, other neurons in the DRG express the p75 gene only and fail
to bind NGF (Verge, et al., 1989a). These other neurons express trkB and trkC (Wright
and Snider, 1995) and bind other members o f the neurotrophin family, BDNF and NT3
(reviewed by Chao, 1992).
A study using transections o f the sciatic nerve and infusions of exogenous NGF
has shown that NGF regulates p75 and trkA in those neurons that bind NGF (Verge, et
al, 1992). Cutting the sciatic nerve removes target-derived NGF and causes a dramatic
decline in DRG neuronal high affinity NGF receptor binding as well as in trkA and p75
mRNA -Intrathecal infusion o f exogenous NGF restores receptor binding and returns
the receptor mRNA levels toward normal.
Not only does NGF regulate its receptors, it has been shown to regulate other
genes in those neurons that bind NGF with high affinity. There is, for example, a well
established relationship between NGF and neuropeptide gene expression in DRG
neurons. An in vitro study by Lindsay and Harmar (1989) showed that NGF regulates
calcitonin gene-related peptide (CGRP) and preprotachykinin (PPT) gene expression in
adult DRG neurons.

The PPT gene encodes the precursor to substance P.

This

undecapeptide is a putative nociceptive neurotransmitter (Duggan, et al., 1987; 1988)
and its depletion results in thermal analgesia (Yaksh, et al., 1979). A later, in vivo study
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showed that the decline in substance P following sciatic nerve transection is reversed by
infusion o f NGF to the proximal cut end o f the nerve (Wong and Oblinger, 1987).
In the same study, Wong and Oblinger (1987) reported that exogenous NGF did
not reverse the decline in lumbar DRG neurofilament gene expression that follows
transection o f the sciatic nerve. Contrary to this report, however, is substantive indirect,
(Gold, et al., 1991) as well as, direct evidence that NGF regulates the synthesis o f
intermediate filaments in, at least, the NGF binding subpopulation o f DRG neurons
(Verge etal., 1990).
Neurofilaments are a major structural component of neurons and are particularly
abundant in large diameter axons (Friede and Samorajski, 1970). These intermediate
filaments are comprised o f three protein subunits, which are encoded by separate genes
(Julien et al, 1986). Neuronal size and axon diameter are proportional to the number of
neurofilaments (Hoffinan, et al., 1988).

Paul Hoffinan and his colleagues, based on

substantive experimental evidence, have argued that neurofilaments are essential to the
maintenance o f axon diameter and thereby, govern conduction velocity (Hoffinan, et al,
1984, 1985, 1987). Moreover, since myelin thickness is correlated with axon diameter,
it follows logically that axonal neurofilament content determines myelin thickness.
Axotomy causes neurofilament synthesis to decline (Oblinger and Lasek, 1988).
Reconnection o f axons with their targets restores neurofilament gene expression and
synthesis (Hoffinan, 1987) suggesting that target-derived growth factors, such as NGF,
regulate neurofilament gene expression. In cultured rat pheochromocytoma cells, NGF
upregulates all three subunits (Lindenbaum, 1988). Moreover, NGF deprivation in vivo
by antibody infusion causes sensory axonal atrophy (Matheson, 1989). This atrophy has
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been tied to decreased neurofilament synthesis (Gold, et al., 1991).

Verge and

colleagues (1990) found that after axotomy, neurofilament synthesis was significantly
decreased in large DRG neurons. Administration o f NGF to the DRG somata restored
neurofilament production in only that small proportion of these large neurons that bind
NGF with high affinity.

They concluded that NGF regulates neurofilament gene

expression in NGF-dependent DRG neurons through some intermediate mechanism. In
the 60% o f the DRG neurons that are not NGF-dependent, neurofilament synthesis must
be regulated by other target-derived factors, perhaps, the other neurotrophins.

Estrogen-NGF Interaction in the Regulation o f DRG Neuronal Gene Expression and
Function
A recent study by Sohrabji and her colleagues (1994) shows that estrogen
receptors co-localizes with neurotrophin receptors in DRGs.

Moreover, circulating

estrogen levels regulate DRG neuronal estrogen receptor gene expression. For example,
at proestrus, when estrogen levels are highest, estrogen receptor mRNA is at its lowest.
In ovariectomized (OVX; estrogen deficient) rats, estrogen receptor mRNA levels are
highest.

Additionally, estrogen replacement to proestrus levels restores estrogen

receptor mRNA levels to their lowest levels.

Thus, as in other systems, estrogen

regulates its receptor.
More importantly, there is evidence that estrogen regulates DRG trkA and p75
gene expression (Sohrabji, et al., 1994).

During proestrus, with the highest estrogen

levels, trkA is up-regulated. Similarly, p75 is up-regulated during proestrus. Sohrabji
and her colleagues (1994) found that OVX down-regulates both o f these NGF receptor
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genes. Unfortunately, it is not entirely clear how to interpret the effects o f replacement
estrogen. They found that estrogen replacement transiently decreased p75 mRNA levels
at four hours post-replacement, while at 52 hours there was no difference in p75 mRNA
levels in DRGs o f OVX rats and OVX rats receiving estrogen. These data suggest that
estrogen, through its action on the NGF receptors, may alter foe sensitivity o f DRG
neurons to NGF.

In this way, estrogen might act in synergy with NGF to regulate

genes necessary for primary sensory neuronal function.
Recent evidence supports foe idea o f such a synergistic interaction between
estrogen and NGF in foe regulation o f CGRP and substance P.

Sarajari and her

colleagues (1995), using immunohistochemistry, reported that there were high levels o f
ER immunoreactivity in only foe small DRG neurons, but not the larger cells. This
finding is somewhat surprising in light o f Sohrabji and her colleagues (1994) data
showing ER mRNA in all large and small DRG neurons. The difference in these findings
might be explained by foe difference in experimental approaches used by the two groups.
The in situ hybridization used by Sohrabji and colleagues (1994) may be a more sensitive
method than foe immunohistochemical method used by Sarajari and colleagues (1995).
This controversial issue, i.e. which DRG neurons express foe ER gene is examined in the
current research.
Regardless, Sarajari and co-workers (1995) were able to co-localize CGRP,
substance P and ER in the smaller DRG neurons. They showed further that CGRP
immunoreactivity was increased in OVX rats receiving estrogen compared to those not
receiving estrogen replacement. Furthermore, they show that this pattern is present at
very early post-natal stages (Sarajari, et al., 1996). Contrary, however, to what might
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be expected based on Lindsay’s and Namur's (1989) report showing up-regulation of
both CGRP and PPT genes by NGF in cultured adult DRG neurons, Sarajari and her
colleagues (1995) reported a decrease in substance P immunoreactivity in estrogentreated OVX rats.

If estrogen does indeed up-regulate the DRG neuronal NGF

receptors, as reported by Sohrabji and her colleagues (1994), and thereby enhances the
sensitivity o f those neurons to NGF, it becomes difficult to understand the differential
regulation o f the two neuropeptides by estrogen reported by Sarajari and her colleagues
(1995).

The answer may depend on an understanding o f the time course o f the

regulatory events.
By contrast, if as Sohrabji and her colleagues (1994) have shown, trkA and p75
are up-regulated by estrogen, one might also expect substance P to be up-regulated. An
up-regulation o f substance P would, in turn, be expected to decrease pain and
temperature thresholds. Evidence supporting this expectation was recently provided in a
study by Frye and her colleagues (1992). They used the tailflick latency to a focused
light beam as a measurement o f thermally induced nociception to examine the effects o f
estrus cycle on pain and temperature. They found significant differences in sensitivity at
different phases o f the cycle. During proestrus (highest circulating levels o f estrogen)
they found the lowest tailflick latencies, while during metestrus (lowest circulating
estrogen levels), the tailflick latencies were at their highest. In the current study the
interrelationships among chronic estrogen administration, trkA gene expression, PPT
gene expression and warm thermal withdrawal latencies are determined.
Not only does NGF regulate substance P gene expression, it also regulates AS
and C fiber afferent collateralization in the skin (Diamond, et al., 1992). Thus, elevated
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circulating estrogen levels should, through their effects on DRG NGF receptor genes,
cause expansion o f the receptive fields for these fibers. This may be the case. Moreover,
neurofilament gene expression and synthesis may be essential for maintenance o f this
collateralization.
Nearly 25 years ago, it was suggested that hormones acted peripherally to
increase skin sensitivity (Komisaruk, et al., 1972: Kow and Pfaff 1973). Three groups o f
investigators Bereiter and Barker (1980), Komisaruk and colleagues (1972), and Kow
and Pfaff (1973) have all found that estrogen replacement increased cutaneous receptive
fields in OVX rats. The mean receptive field size o f the pudendal nerve in treated rats
was 22% larger than that in untreated OVX rats (Kow and Pfaff, 1973). Bereiter and
Barker, (1975) expanded our understanding of this phenomenon by demonstrating
receptive field enlargement in skin o f the facial region in OVX rats which were given
replacement estrogen, in addition to the genital skin areas which had been studied by
these earlier investigators.

Estrogen and the Estrogen Receptor
Because the work in this dissertation is focused on the effects o f estrogen on one
o f its recently discovered target tissues, the DRG, not on the intricacies o f genetic
activation, little attention will be focused at the molecular level, as is true o f the issues
concerning gene activation. In this body o f work, molecular biology is used as a tool for
achieving the research aims o f this study. Nonetheless, a basic description and an
understanding o f the current thinking on these mechanisms is necessary in order to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14

interpret some o f the apparently disparate results o f previous research and is included at
this time.
There are three categories o f steroid hormones: the adrenal steroids, vitamin D3
and the sex steroids. Estrogen as well as progesterone and testosterone comprise the sex
hormones. These and other steroid hormones are derived from cholesterol. Cholesterol
is one o f the most basic and one o f the phylogenedcally oldest molecules o f life since it
is an important component o f the cell membrane (Evans, 1988).

The ovary is

responsible for the production o f circulating estrogen in the adult female. The other
major sex hormones produced by the ovaries are progesterone and the androgens which
are comprised mostly o f testosterone and androstenedione. The circulating levels o f
these hormones vary greatly depending on the stage o f the menstrual cycle o f the adult
human female or the corresponding estrous cycle o f the rat.

The interactions o f these

sex steroids are extremely important but are well beyond the scope o f the body o f
information presented in this paper.
The two major components o f estrogen are estradiol and estrone.

Their

molecular derivation, as well as that o f testosterone, is depicted in Figure 1 (modified
from Stryer, 1987). These two estrogens can be converted into 40 known metabolic
products, although most o f these are intermediate breakdown products destined for
excretion (Erickson and Scheiber, 1995). A few o f these metabolites are biologically
active. If the estradiol or estrone molecule becomes hydroxilated at the 2 or 4 position,
they become known as catechol estrogens. Although the significance o f these molecules
is not understood, one study finds relatively high concentrations o f these estrogen forms
in the pituitary and hypothalamus (Paul and Axelrod, 1977).

Also, the molecular
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configuration (conformation) o f estradiol (17-beta estradiol vs. 17-alpha estradiol) may
prove to be important for biological activity.
How do hormones have such diverse effects within the body? In order for any
circulating hormone to have an effect upon a particular target organ it binds to receptors
of the cells o f the various tissues. Until a few years ago, a discussion o f the ER would
have been quite simple. A newly emerging picture, however, is much more complicated.
The ER,

along with

other steroid

hormone receptors,

glucocorticoid

and

mineralocorticoid receptors and the sterol vitamin D receptor comprise a “superfamily”
of receptors. And although the ligands are dissimilar, the receptors for retinoic acid
(Vitamin A) also show considerable homology to the hormone receptors. The first
formulation o f the nature o f the ER occurred in the early 1970’s with the use o f
radioactive ligands (Evans, 1988). It had been determined earlier

that the action o f

estrogen was not due to local metabolism within the tissue, since when estrogen was
administered at physiological doses, it was retained within the target tissue (Jensen,
1960). This original observation led to the search for hormone receptors in general, and
specifically estrogen receptors.
A widely accepted view arose that ERs resided in the cytosol and, when bound
by hormone migrated to the nucleus where the complex bound to the DNA strand. The
now, more widely accepted view was presented in back-to-back Nature papers by King
and Greene (1984) and Gorski and colleagues (Weishons et al., 1984). The first paper
localized occupied and unoccupied ERs within the nuclei o f cells.

This evidence

suggested that since unoccupied receptors can be found in the nucleus, cytosolic
receptor binding was not a prerequisite for estrogen’s action. The second paper, partially
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reinterpreting their earlier results, presented evidence that the presence o f estrogen
receptors in the cytosol was largely o r wholly artefactual due to methodology.

In

summary, although the idea o f translocation o f estrogen bound to its receptor from the
cytosol to the nucleus has a few proponents, that theory has been discarded. Current
techniques are able to demonstrate few o r no estrogen receptors in the cytosol. Instead,
they are believed to be confined to the nucleus. Some evidence exists that the site of
new receptor synthesis is on the outer surface o f the nuclear membrane and that the
newly formed receptor moves to the interior o f the nucleus at, or shortly after the time o f
synthesis (Tumohimaa, et al., 1988). Another variation o f this idea is that the newly
bound receptors, which are molecular monomers, bind with another and pass to the inner
side of the nuclear envelope as a dimer (Carson-Jurica et al., 1990).
Another evolving theory, which is gaining support, has to do with the nature of
the unbound receptor. Steroid receptors are now referred to as being inactive when not
bound by specific ligands (Carson-Jurica et al, 1990). When hormones enter the cell, the
receptors become activated or transformed. The inactive state o f the ER is now believed
to be dependent upon the receptor’s association with one or more intracellular proteins.
Currently, heat shock proteins, especially HSP 90, are believed to be the particular
proteins which competitively bind to the DNA binding location o f the receptor complex
(Ing and O’Malley, 199S). Additional evidence indicates that this binding apparently
works by more than simple competition for binding sites since experimental removal of
the HSPs from unbound receptors does not activate them (Meshinchi, 1988).

A

conceptualization o f theorized interactions o f the estrogen receptor with its ligand is
presented in Figure 2 (modified from Carson-Jurica, 1990).
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Regardless o f whether or not a different receptor type is present in the cytosol or
nucleus, an entire new category of non-traditional steroid receptor is beginning to be
elucidated. Evidence for a membrane receptor comes predominantly from physiological
experiments (Mermdstein, 1996).

Although previous investigations have been

accumulating evidence that identified neural areas with no known cytosolic or nuclear
estrogen receptors, few have postulated the heretical mechanism o f a hormone
membrane receptor to explain results.

Mermelstein

and coworkers (1996) have

presented evidence that estrogen may also act on a membrane calcium channel in CNS
neurons.
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Figure 1. Depiction o f the estrogen molecule, its molecular derivation and relationship
to other steroid hormones. Note that both major components o f estrogen, estrone and
estradiol are shown.
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Figure 2. Schematic presentation o f the estrogen receptor and how it is believed to act.
The estrogen molecule (E) passes throughthe plasma membrane and binds to the
inactive estrogen receptor (ER) which is positioned in the outer nuclear membrane. In
its inactivated state the ER is bound by a heat shock protein (HSP). When the receptor
is bound by the estrogen molecule, the heat shock protein drops o ff and the bound
estrogen receptor binds to another ER complex (RC) and passes through the nuclear
envelope as a dimer where irattaches to asite on the gene known as the estrogen
response element (ERE).
At this pointthe gene is activated and transcription
commences. The resulting mRNA moves to the cytosol where translation occurs.
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GOALS OF THE CURRENT STUDY
The current research had two main goals. The first goal was to settle the
controversial issue o f whether all or only a subpopulation o f DRG neurons express the
estrogen receptor gene. To this end, in situ hybridization with an anti-sense RNA probe
to the rat ER was used to localize ER mRNA in sections o f lumbar DRGs.
The second, main objective o f the current study was to analyze the
interrelationships among long-term estrogen administration, trkA gene expression, PPT
gene expression and warm thermal withdrawal latencies. Specifically, the hypothesis
tested by the current study was that estrogen upregulates trkA and by doing so, increases
the sensitivity o f NGF-receptive neurons to the growth factor. Furthermore, if long term
estrogen treatment increases the sensitivity of DRG neurons to NGF, the known NGFdependent genes, PPT and 68kD neurofilament should, consequently, be upregulated.
To test this hypothesis, the effects of long-term estrogen treatment on high
affinity NGF receptor (trkA) mRNA levels was examined using quantitative in situ
hybridization with an anti-sense RNA probe to trkA Additionally, similar methods were
used to examine the effects o f long-term estrogen on PPT and 68kD neurofilament
mRNA levels. Finally, a behavioral correlate o f changes in PPT gene expression was
examined. The Hargreaves’ method to measure withdrawal latencies to warm thermal
stimuli in response to long-term estrogen treatment was done with a plantar test
apparatus.
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METHODS
Animals and Experimental Groups
Forty-three adult female OVX Sprague-Dawley (Harlan Sprague Dawley) were
used for this study. Animals were purchased, maintained and treated according to the
Eastern Virginia Medical School Animal Care and Use Committee standards and the
NIH Guide fo r d»e Care and Use o f Laboratory Animals (approved protocols are on file
in the Office o f Research). The rats, weighing 200-300 grams at the commencement of
the study, were randomly assigned to three groups two weeks post-ovariectomy.
Rats in the first group were ovariectomized with no estrogen replacement. This
group is referred to as the OVX group. Bilateral ovariectomies were done at the Harlan
facilities.

Those in the second group were ovariectomized and received daily

subcutaneous estrogen (Premarin, Wyeth-Ayerst) injections at a dose (0.022mg/kg)
calculated to result in physiological serum estrogen titers (Washburn, et al., 1993) This
group is referred to as IX, the low dose group. The rats in the third group were
ovariectomized and given replacement estrogen subcutaneously at 10 times the daily
dose (0.22mg/kg) given to Group 2. This group is referred to as 10X, the high dose
group.
Normal, age-matched female rats provided baseline uterine weights for
assessment o f the effects o f estrogen treatments (see Figure 3 in Results). During the
length o f the study, all animals were housed in community cages with 3-4 animals per
cage at the EVMS animal care facility.

All subjects were given unlimited standard rat

chow and water. The day-night cycle was maintained at 12 hours each of light and dark.
Animals in the three groups were killed after either 56 or 90 days o f estrogen treatment.
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Warm Thermal Perception Testing
The Hargreaves' method for testing warm thermal perception used the Plantar
Test Apparatus (Ugo Basile Biological Research Apparatus, Co.)- This apparatus used a
light (heat) source capable o f emitting a focused light beam. The source was positioned
under the hind paw o f the rat subject which was confined in an elevated plexiglas
compartment. The beam was manually started and when the beam was interrupted by
foot withdrawal the trial was automatically terminated. The apparatus' timing device
measured the trials in tenths o f seconds. A detailed explanation o f this apparatus is
reported by Hargreaves (1988). Subjects assigned the 90 day survival time were tested
daily for seven days beginning at day 80. The order o f testing was chosen blindly and
subjects were identified after their trial.

Tissue Harvest and Preparation
After 56 days, three rats from each o f the three groups were euthanized. After
90 days the remaining 34 rats were killed. After receiving a lethal overdose o f a mixture
of ketamine and xylazine, (160 mg/Kg ketamine, 16 mg/Kg xylazine) the animals were
perfused through the ascending aorta with physiological saline followed by 10%
phosphate-buffered formalin. The dorsal root ganglia were removed bilaterally from L4L6 and collected into fresh 10% buffered formalin. Uteri from the 90-day animals and
age-matched normal females were harvested and weighed.

The DRGs were embedded

in low melting point paraffin with special precautions taken to prevent RNAse
contamination. Following embedding, 5pm sections were cut on an American Optical
paraffin microtome and placed on Fisherbrand Superfrost slides.
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Probe Synthesis and in situ Hybridization

The ER cDNA used for antisense and sense RNA probe synthesis was a 560 base pair
fragment from the N-terminus incuding a portion o f the binding pocket unique to the
estrogen receptor It was a gift from Dr. Paul Shugrue (Wyeth-Ayerst) and was used
with permission o f the originator, Dr. M. Muramatsu. The sequence was described by
Koike and colleagues (1987).
The trkA cDNA was obtained from Genentech. It was a 545 base pair fragment
taken from the extracellular domain. The PPT cDNA was a 560 base pair fragment
identified as beta PPT. The DNA fragment used was from a gene region which is
uniquely a precursor to substance P (Krause, et al, 1987). It was obtained from Dr.
Susan Leeman at Harvard University. The neurofilament cDNA was a 1.2kB fragment
cloned from the gene specific for the 68 kD neurofilament subunit (Lewis and Cowan,
1985). It was a gift from Dr. Oswald Steward, University o f Virginia, and used with the
permission o f its originator, Dr. Nick Cowan at New York University.
Detailed technical protocols for probe synthesis and in situ hybridization are
included in the Appendix. Briefly, sense and antisense RNA probes were radiolabelled
with p33 UTP using a Promega probe synthesis kit (Promega Riboprobe In Vitro
Transcription System). Unincorporated isotope was removed by filtering through a TE
Midi Select Column (Sigma). After the addition o f tRNA, the probes were shortened
to approximately 150 base pairs by alkaline hydrolysis.

Probes were precipitated

overnight, then pelleted, resuspended and counted with a scintillation counter to
determine radionucleotide incorporation. Protocols for radioisotope usage have been
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approved by the EVMS Radiation Safety Committee and are on file in the Office o f
Research.
Tissues were examined by in situ hybridization techniques to localize mRNA for
rat estrogen receptor.

Quantitative m situ hybridization was used to localize and

quantify trkA, the high affinity NGF receptor, preprotachyldnin (PPT; the substance P
precursor) and 68kD neurofilament mRNAs.
Sections were given a pretreatment, hybridized, and post-hybridized.

In the

pretreatment, the sections were deparaffinized with xylene and rehydrated in graded
alcohols. The sections were then permeablized in a 0.2% HC1 bath and incubated in
proteinase K at 37°C. The sections were fixed in formaldehyde then acetylated with
0.1M triethanolamine

with 0.25% acetic anhydride.

After rinsing, sections were

dehydrated in graded alcohols, delipidated with chloroform and dried under vacuum.
During hybridization, tissue sections were treated with sense and antisense
probes which were added to the hybridization solution consisting o f 50% formamide,
,3MNaCl, 20mM Tris-HCl, EDTA, Denhardt’s solution, salmon sperm DNA, Torules
Yeast RNA, DEPC treated water and dextran sulfate pipetted onto the slides and
incubated overnight in a 60°C humid chamber. In the post-hybridization portion o f the
procedure, slides were washed, dehydrated and Rnase treated. Slides were again washed
and dehydrated, then exposed to Hyperfilm-beta (Amersham, Arlington Heights, 111) for
2-4 days. Slides were coated with Kodak NTB2 nuclear emulsion diluted at a 1:1 ratio
with distilled water, and after 6-21 days (for TrkA, neurofilament and ppt) were
developed with a Kodak Dektol and Kodak fixer. Slides were stained for microscopic
analysis with a hematoxylin and eosin preparation or cresyl violet.
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Quantification o f Silver Grains
The in situ hybridations were quantified by an Image I (Universal Imaging
Corporation) image analysis system according to the method o f McNamara (1993). For
this study, slides were blindly coded and non-overlapping

fields o f neurons were

counted. Areas with large numbers o f axons were not included. At least 10, and up to
40 observations were made for each slide. A minimum o f two slides was used for each
subject which

served as an internal control for consistency.

That is, if specific

hybridization was detected on one slide but not on another, the case was discarded.
Background counts were made from glass adjacent to the tissue sections and subtracted
from the field counts.

Sense slides were examined for signal.

Statistical Analysis
A mixed model ANOVA statistical analysis was performed on numerical data
collected during grain counting from the in situ hybridization slides. Analysis o f the foot
withdrawal data was performed with a seven-by-three repeated measures ANOVA.
The choice o f the tests were recommended and the analyses performed by Paul Kolm,
Ph.D., the biostatistician at EVMS.
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RESULTS
At the time o f euthanization, the absence o f ovaries was confirmed in all
experimental animals. Figure 3 is a histogram comparing mean uterine weights o f the
three experimental groups with the mean uterine weight o f normal cycling females. The
distinct differences between the mean weights o f OVX versus estrogen-replaced or
normal uteri was considered ample proof o f the removal o f endogenous estrogen by
ovariectomy and restoration o f circulating estrogen in the treated animals.
reviewing these data, Gerald Pepe, Ph.D. (personal communication),

Upon

an expert on

estrogen and estrogen treatment, suggested that no further assay was needed as
verification o f estrogen status.

Estrogen Receptor mRNA Localization in Lumbar DRG
Micrographs showing the localization o f ER mRNA within the DRG o f an OVX
animal from Group 1 by in situ hybridization with the ER RNA probe are presented in
Figure 4.

The darkfield micrograph clearly reveals detectable ER mRNA in a

subpopulation o f predominantly smaller DRG neurons.

The higher magnification

brightfield micrograph shows mRNA localization in smaller neurons (arrow). Larger
neurons were generally unlabelled by hybridization with the antisense RNA probe to the
rat ER. The sense probe verified the specificity o f the antisense probe and revealed no
hybridization to the DRG sections (data not shown).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

27

0.45

0.4

0.35 r

0.3
STOSS
tosSzSttsS

?HiS

□ovx

0.25 -

Mi;:

<n

1 0.2 +

□ 1X
■ 10X
□sham

O
0.15

0.1

-

II

0.05

Figure 3. Bar graph comparison o f uterine weights across groups. Low weights confirm
a lack of circulating estrogen in the OVX group. Note that replacement groups means and
the sham operated group mean were nearly three to five times that o f the OVX group.
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Figure 4. Darkfield micrograph showing localization o f estrogen receptor mRNA in a
lumbar DRG by in situ hybridiation (A). The same section in brightfield illumination and
at a higher magnification is shown in (B). Bar in darkfield is 100pm. Bar in brightfield
is 50pm. The arrows identify the same cluster o f neurons in both micrographs.
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Effects o f Estrogen Treatments on High Affinity Nerve Growth Factor Receptor (trkA)
mRNA Levels
Results o f the in situ hybridization studies using the RNA probe for the high
affinty nerve growth factor, trkA, are presented in Figures 5-9. Figure 5 compares the
hybridization o f the probe to DRG sections from the three groups after 56 days o f daily
estrogen treatment in the IX and 10X groups. Figures 5A and 5B are darkfield and
brightfield micrographs o f a DRG section from an OVX animal. The trkA mRNA was
observed mostly, but not exclusively, in small diameter DRG neurons. Micrographs C
and D (IX treatment) and E and F (10X treatment) reduces the hybridization o f the trkA
probe to the tissue indicating reductions in the amounts o f trkA mRNA in these tissues.
Two separate in situ hybridization experiments were done.

Quantitative

comparisons o f results were performed on tissues hybridized at the same time under
identical conditions.

Results o f the quantification and statistical analyses o f trkA

experiment 1 are shown in Figure 6. After 56 days o f estrogen replacement the mean
trkA steady state level o f the OVX group was 2472.47 grains per region area (gr/rA)
with a standard deviation o f 1746.57 gr/rA. The mean trkA steady state level for the
IX group was 1629.9 gr/rA with a standard deviation o f 826.9 gr/rA while the mean
level for the 10X group was 2084.42 gr/rA with a standard deviation o f 1318.22 gr/rA.
Statistical analyses revealed that the mean trkA for the OVX was significantly greater
than that o f the IX group (p - .0115).

The statistical difference difference between the

IX group and the 10X group was not significant. The treatment group effect was
significant (p = .0159).
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Figure 7 is a histogram showing the results o f the quantitative analyses o f the
hybridization o f the trlcA probe to the DRGs in in situ hybridization experiment 2. This
experiment was performed in a manner identical to experiment 1, but on DRG sections
from different animals from the three groups. The mean steady state mRNA level for the
OVX group was 5320.75 gr/rA with a standard deviation o f 3928.98 gr/rA The mean
steady state trkA mRNA level for the IX group was 3654.26 gr/rA with a standard
deviation o f 1844.74 gr/rA while that for the 10X group was 3846.8 gr/rA with a
standard deviation o f 2364.17 gr/rA

Statistical analyses revealed that the mean steady

state trkA mRNA level o f the OVX group was significantly greater than the mean o f the
IX group (p=.0273). The differences between the OVX and the 10X group was nearly
significant (p= .0583).
Figure 8 consists o f micrographs showing the results o f hybridization o f DRG
sections from the three groups with the trkA RNA probe after 90 days of estrogen
treatment. The qualitative results o f the longer-term treatment are similar to those o f the
56-day treatment, i.e. estrogen treatments reduce the amounts o f trkA mRNA in
predominantly smaller DRG neurons.
The results o f quantification o f silver grains indicating trkA mRNA in the DRG
sections from the three groups after 90-day o f estrogen treatments are presented in
Figure 9. The mean steady state trkA mRNA level for the OVX group was 661.56
gr/rA with a standard deviation o f 429.41 gr/rA That for the IX group was 424.86
gr/rA with a standard deviation o f 272.04 gr/rA while the mean steady state trkA
mRNA level for the 10X group was 424.86 with a standard deviation o f 201.39. In the
case o f 90 days of estrogen treatments, statistical analyses showed that the mean steady
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state trkA mRNA level for the OVX group was significantly greater than those from
either estrogen replacement group (p< .0001).
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Figure 5. Comparison o f results o f in situ hybridization o f DRG sections with an anti
sense probe to trkA mRNA after 56 days o f estrogen replacement. Micrographs A, C
and E are shown in darkfield. Micrographs B, D and E are shown in brightfield, at a
higher magnification. Sections A and B are from an OVX animal. Sections C and D are
from a IX animal. Sections E and F are from a 10X animal. All darkfield micrographs
are at the same magnification (Bar=100|im). Brightfield micrographs are at the same
magnification (Bar=50pm).
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Figure 6. Histogram comparing steady state trkA mRNA levels in the DRG in OVX and
estrogen treated groups after 56 days o f treatment, (experiment 1)
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Figure 7. Histogram comparing steady state trkA mRNA levels in DRG by in situ
hybridization after 56 days o f estrogen replacement, (experiment 2) Subjects used for this
experiment are from the same pool o f subjects within each group, but are not identical to
those used in experiment 1.
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Figure 8. Comparison o f results o f in situ hybridization o f DRG sections with anti
sense probe to trkA mRNA after 90 days of estrogen replacement. Micrographs A, C
and E are shown in darkfield. Corresponding sections are shown at a higher
magnification in brightfield in B, D and F. Sections shown in A and B are from an OVX
animal. Sections shown in C and D are from a IX animal. Sections shown in E and F
are from a 10X animal. Darkfield micrographs are at the same magnification (Bar=100
fim). Brightfield micrographs are at the same magnification (Bar=50 nm). Arrows
indicate the same neurons in darkfield and brightfield.
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Figure 9. Histogram comparing trkA mRNA levels in OVX and estrogen treated groups
after 90 days. Means in the replacement groups are significantly lower from that o f the
OVX group (p <0.0001 for both comparisons).
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Effects of Estrogen Treatments on Preprotachvkinin (PPT) mRNA Levels
Results o f the in situ hybridization experiments using an RNA probe for the PPT
gene are presented in figures 10-13. Figure 10 is a comparison o f micrographs o f DRG
sections hybridized with the PPT probe from the three treatment groups after 56 days o f
treatments. The PPT mRNA, as would be expected from previous studies showing
localization o f substance P peptide, was found mainly in smaller DRG neurons. The
estrogen treatments appeared to reduce the amount o f mRNA in DRG sections from the
treated groups.
A histogram comparing mean steady state PPT mRNA levels across the three
groups after 56 days o f estrogen treatments is shown in Figure 11. The mean steady
state level PPT mRNA level for the OVX group (1521 gr/rA) was greater than either the
mean steady state PPT mRNA levels for the IX treatment group (901 gr/rA) or the 10X
treatment group (836 gr/rA).
After 90 days o f treatments, PPT steady state mRNA levels were decreased by
estrogen replacement therapies, as was observed after 56 days o f estrogen treatments.
These data are shown in the comparison o f micrographs in Figure 12. As was seen after
56 days of treatment, there is an apparent decrease in the numbers o f silver grains
indicative of PPT mRNA localization over the DRG sections from the estrogen treated
animals.
A histogram depicting quantification o f these differences is shown in Figure 13.
Here, the mean steady state PPT mRNA level for the OVX group was 661.56 gr/rA with
a standard deviation o f 429.41 gr/rA. That for the IX group was 421.33 gr/rA with a
standard deviation o f 272.04 gr/rA, while the mean steady state PPT mRNA level for the
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10X group after 90 days o f estrogen treatment was 424.86 gr/rA with a standard
deviation o f 201.39 gr/rA. The mean steady state PPT mRNA levels for both estrogen
replacement groups were significantly lower than the that for the OVX group (p <
.0001).
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Figure 10. Comparison o f results o f in situ hybridization o f DRG sections with anti
sense probe to preprotachykinin (PPT) after 56 days o f estrogen replacement.
Micrographs A, C and E are shown in darkfield, and micrographs B, D, and F are shown
in brightfield, at a higher magnification. Sections shown in A and B are o f an OVX
animal. Sections shown in C and D are from a IX animal. Sections shown in E and F
are from a 10X animal.
Micrographs A, C and E are at the same magnification
(Bar=100 pm). Micrographs B, D and F are at the same magnification (Bar=50 pm).
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Figure 11. Histogram comparing o f PPT mRNA levels in OVX and estrogen treated
groups after 56 days.
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Figure 12. Comparison o f results o f an in situ hybridization with an antisense probe to
PPT after 90 days o f estrogen replacement.
Sections A, C and E are darkfield
micrographs. Sections B, D and F are higher magnification brightfield micrographs.
Sections A and B are from an OVX animal. Sections B and C are from an animal
receiving IX replacement estrogen. Sections D and F are from an animal receiving 10X
replacement estrogen. Micrographs A, C and £ are at the same magnification (Bar=100
Jim). Micrographs B, D and F a re at the same magnification (Bar=50 pm).
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Figure 13. Histogram comparing PPT mRNA levels in OVX and estrogen treated groups
after 90 days. Means for replacement groups are significantly lower than the OVX group
(p <0.0001 for both comparisons).
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Effects o f Estrogen Treatments on Warm Thermal Withdrawal Latencies
Results o f the thermal withdrawal test indicate a trend o f reduced thermal
sensitivity when estrogen replaced groups were compared to the OVX animals. Results
o f the analyses o f warm thermal withdrawal latencies as measured with the warm plantar
withdrawal testing apparatus are presented in Figure 14. These data were analyzed by a
three (group) by seven (day) repeated measures analysis o f variance (ANOVA).

The

mean withdrawal latency for the OVX estrogen treatment group was less (meaning a
shorter time for foot withdrawal) than that for the IX estrogen treatment group which
was, in turn, less than the mean withdrawal latency for the 10X group. On a daily basis,
this phenomenon, though small, is surprisingly consistent. It is true for 18 out o f 21
means. However, the repeated measures ANOVA did not find significant differences for
the main effect, that is a comparison o f means for all subjects between groups.

Each

group terminated their trials significantly foster with repeated measurements, i.e., there
was a day effect (p=.0014 ). The amount o f this decline was not significantly different
between groups.
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Effects o f Estrogen Treatments on 68kD Neurofilament mRNA Levels
Dramatic qualitative differences in hybridization o f the probe to these tissues are
demonstrated. The 68kD neurofilament mRNA is most abundant in larger DRG neurons
although all DRG neurons express the gene. Estrogen treatments dramatically increase
the density o f the silver grains over the larger neurons indicating increased steady state
68kD neurofilament mRNA levels.

The results o f in situ hybridizations using an RNA

probe to the 68kD neurofilament gene are shown in Figures 15-18. Figure 15 shows
micrographs comparing the results o f hybridization with the 68kD neurofilament
antisense probe to DRG sections from the three groups after 56 days o f estrogen
treatment
Figures 16 and 17 show quantitative results o f these differences and reveal a
possible dose-dependent effect o f estrogen treatment on 68kD neurofilament gene
expression. Similar to the data presented for trkA, experiments 1 and 2 use subjects
from the same pool but are not identical. In the first experiment, the mean steady state
68kD mRNA level for the OVX group was 540.10 g/rA

That for the IX estrogen

treatment group was nearly four times greater (2069.85 g/rA), while that for the 10X
estrogen treatment group was nearly six times greater (3279.35 g/rA).

Statistical

analyses revealed that these differences among groups were significant (p> .0001).
In the second in situ hybridization experiment, the mean steady state 68kD
neurofilament mRNA level for the OVX group was 1259.95 g/rA the mean for the IX
estrogen treatment group was nearly three time greater (3013.8 g/rA) while that 10X
estrogen treatment group was nearly five times greater (5132.85 g/rA).

Statistical
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analyses o f these data, as for the first experiment, differences among groups that are
significant (p>.0001).
Figure 18 shows the results o f quantification o f mean steady state 68lcD
neurofilament mRNA levels for the 90 day estrogen treatment regimen. These data vary
slightly from the results o f the 56 day treatment regimen. Following 90 days o f estrogen
treatments, the mean steady state 68kD neurofilament mRNA levels were nearly three
times greater in the treatment groups (IX : 2952.35 g/rA 10X: 3426 g/rA) as compared
to those o f the OVX group (1145.8 gr/rA). On the advice o f Dr. Kolm, statistical
analyses were not performed on these data since it was not possible to obtain grain
counts from equal numbers o f DRG areas for the 10X group.
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Figure 15. Comparison o f results o f in situ hybridization o f DRG sections with antisense probe to neurofilament (68 kD) after 56 days o f estrogen replacement.
Micrographs A, C and E are shown in darkfield, and micrographs B, D and F are shown
at a higher magnification with brightfield illumination. Sections shown in A and B are
from OVX animal. Sections shown in C and D are from an animal receiving IX
replacement estrogen. Sections shown in E and F are from an animal receiving 10X
replacement estrogen. Bars in darkfield micrographs, A, C, and E are 100 pm. Bars in
brightfield micrographs B, D, and F a re 25 pm.
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Figure 16. Histogram comparing neurofilament mRNA levels in OVX and estrogen
treated groups after 56 days, experiment 1. All means are statistically different from each
other (p< .0001).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

55

6000

□ OVX
□Low Dose
■ High Dose

Figure 17. Histogram comparing neurofilament mRNA levels in OVX and estrogen
treated groups after 56 days, experiment 2. Sections are from the same pool o f subjects
as in experiment 1. All means are statistically different from each other (p <.0001).
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treated groups after 90 days.
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DISCUSSION
The current study demonstrates that long-term estrogen replacement in OVX rats
has profound effects on a number o f important DRG neuronal genes. Long-term
estrogen replacement down-regulates the the high affinity NGF receptor, trkA gene, as
well as, the PPT gene, which is responsible for the synthesis o f the putative nociceptive
neuropeptide, substance P. In addition, long-term estrogen administration dramatically
increases 68kD neurofilament mRNA levels. These findings are among the first to
suggest direct effects o f long-term estrogen treatment on primary sensory neuronal gene
expression. Such evidence provides initial insight into mechanisms that underlie altered
somatosensory function during the reproductive cycle o f rats.
More importantly for the millions o f women facing loss o f estrogen, they suggest
potential effects o f estrogen replacement therapy on skin sensation. The use o f estrogen
replacement therapy for these women, to treat the obvious consequences o f estrogen
loss, such as osteoporosis, is gaining greater acceptance. The implications o f the data
from the current study for the increasing use o f estrogen replacement therapy in
menopausal women are obvious.

The form, dosage, and time-course o f estrogen

replacement may be critical and may depend on the specific symptoms and systems being
treated. While chronic, long-term estrogen therapy might be beneficial in the treatment
o f some systems, such as the skeletal or cardiovascular systems, the current data suggest
that chronic, long-term estrogen treatment may alter somatosensory function and
perhaps, in some instances, particularly nociception, have a deleterious effect.
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Estrogen Receptor Gene Expression in Lumbar DRGs
There has been a controversy in the literature regarding the number and types o f
DRG neurons that express the ER gene. Sohrabji and her colleagues (1994) reported
that ER mRNA was present in all DRG neurons. In contrast to these data, Sarajari and
her colleagues (1996) reported that ER gene expression was characteristic o f a
subpopulation o f predominantly smaller DRG neurons.
One goal of the current study was to resolve this controversy by determining
whether all or only a subpopulation o f DRG neurons express the ER gene. The results
of eight separate in situ hybridization experiments using probes to localize ER rmRNA
within the lumbar DRG support those reports showing ER gene expression in only
smaller DRG neurons (Sarajari and Oblinger, 1996). However, the final resolution of
this issue may ultimately depend on methods with greater sensitivity for the detection o f
very low abundance mRNA in tissue sections.
To date, few photomicrographs o f ER mRNA have been published which use a
radioactive label. It is difficult to compare results on the basis o f description alone. Only
Simerly (1990) has published photomicrographs showing ER mRNA localization in the
hypothalamus using this method. No one has published similar data for the spinal cord
and DRG, both regions purported to have neuronal ER expression.
Cell biologists have suggested that ERs are largely recycled, that is, they return
to the outer nuclear envelope after they detach from the estrogen response element of
the gene (Ing and O’Malley, 1995).

If this is the case, the mRNA needed for the

production o f new receptors may be very low in abundance making it particularly
difficult to detect by conventional in situ hybridization methods.
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In the current study, our in situ hybridization methodology revealed the results o f
hybridization with radioactive probes to such high abundance mRNAs as 68kD
neurofilament, PPT, and trkA within 1-2 weeks o f exposure o f the labelled slides to the
NTB2 emulsion. By contrast, the m situ experiments yielding the best results for ER
mRNA localization were exposed for 4-5 weeks or longer. Indeed, Oblinger (personal
communication) used 16 week exposures to emulsion to reveal ER mRNA localization.
Therefore, it remains a possibility that all DRG neurons may express the ER gene, but
the technique available to us only allowed visualization o f ER mRNA in some smaller
neurons, where steady state ER mRNA levels are maximal. Quanitative analysis o f in
situ hybridizations may be ineffective as a method o f data analysis for low abundant
mRNAs.

The report showing ER mRNA localization in all DRG neurons used a

digoxygenin labelling methodology (Sohrabji, et al., 1994).

There is little reason,

however, to believe that that particular approach is more sensitive than one using
radioactively labelled RNA as a probe.
Differences in the fragment o f the ER gene selected for probe synthesis is another
variable that may add to the disparity between studies. Sohrabji and her colleagues
(1994) used a 48-base pair oligonucleotide probe constructed at their own university.
All other in situ hybridization studies o f ER expression in nervous tissue use variations
o f the cDNA probe cloned by Miramatsu (Koike, et al., 1987). Because o f the very
large degree o f homology with other hormone receptors, it is critical to select the
fragment for the probe from a portion o f the region coded for the receptor binding
pocket. Both the Sohrabji group and the Sarajari group appear to accommodate this
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requirement. This region has very little homology with the binding pockets o f other
hormone receptors.
In exploring the effects o f estrogen on nervous tissues, one must also consider
potential non-genomic actions o f the hormone. The possibility that estrogen may enter
DRG neurons by an as yet undescribed, additional route which bypasses the traditional
ER is intriguing,

fin general, non-genomic estrogen effects should be identifiable by

their short latencies. These latencies are measured in minutes rather than hours and, as
such, were beyond the resolution provided by the current study.

Regulation o f NGF Receptor Genes bv Estrogen
Clearly many questions remain concerning the relationship between estrogen and
the neurotrophin, NGF. In order to begin to understand this relationship, one must begin
by analyzing the effects o f estrogen on the low-affinity (p75) and high-affinity (trkA)
NGF receptors. The current study has established the effects o f long-term estrogen
treatment on trkA mRNA levels. Others have studied estrogen’s effects on the lowaffinity NGF receptor, p75 (Gibbs and Pfaff 1992, Sohrabji et al, 1994 and ToranAllerand et al, 1992).
Without first considering the effects o f estrogen, one finds that there remains
some confusion about the interaction between p75 and trkA.

The roles o f these two

receptors in mediating NGF’s action are not entirely understood. Emerging evidence
indicates that p75, which may, more properly, be referred to as the neurotrophin
receptor, influences the sensitivity o f DRG neurons to whichever of the tyrosine kinase
type o f receptors that they co-expressed, e.g. trkA, trkB or trkC (Wright and Snider,
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1995). Thereby, p75 may, in some way, determine the sensitivity o f a trkA expressing
DRG neuron to NGF or a trkB expressing neuron to brain derived neurotrophic factor (
BDNF).
Because high affinity NGF binding and the intracellular effects o f NGF on DRG
neurons is dependent on trkA expression, the current study focused on the effects o f
long-term estrogen treatment on trkA gene expression.

In the current study, trkA

mRNA levels were clearly and significantly downregulated by both IX and 10X daily
estrogen treatments over 90 days. Treatments over the shorter, 56-day time period had
similar effects.
These data show that chronic, long-term estrogen treatment decreases the
amount o f trkA mRNA in lumbar DRG neurons. Such a decrease would be expected to
decrease the production o f high-affinity NGF receptors by DRG neurons and thereby
decrease the sensitivity o f these cells to the neurotrophin. This, in turn, should downregulate NGF-dependent gene expression in the DRG. Further data from this study
fulfill this expectation by showing a coincident effect o f estrogen treatments on DRG
PPT gene expression.

Effects o f Estrogen Treatments on PPT Gene Expression and Nociception
As stated earlier, about 40% o f DRG neurons bind NGF and express the trkA
gene. O f these, about half express the PPT gene. In those 20% o f DRG neurons, PPT
gene expression (Hamar and Lindsay, 1989) and therefore, substance P levels (Wong and
Oblinger, 1992) are regulated by NGF.

Since, as discussed above, chronic, long-term
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estrogen treatment decreases DRG trkA. mRNA levels, it should have a downstream
effect on NGF-regulated genes, such as the PPT gene.
The current data reveal a dose relationship between the effects o f chronic, long
term estrogen treatment on trkA mRNA levels and the effects on PPT mRNA levels.
Both 56 and 90 days o f daily estrogen treatment decreased PPT mRNA levels in both
replacement groups compared to those o f the OVX groups. After 56 days the result is
apparent.
Other than means, statistical analysis was not performed for the 56-day group for
the following reason.

This was because only a small tissue section was available for

one animal (please see Methods) and only five data points were collected from one slide.
Due to the restrictions o f the statistical test, i.e., an entirely balanced format,

the

decision was made to include data collected at the rate o f 10 data points per slide per
animal for all other slides rather than discard half o f the data. (115 data points were
collected rather than 120). However, no portion of this data is inconsistent with that for
the 90-day group in which PPT mRNA levels in both replacement groups were
decreased in comparison to that o f the OVX group. It is important to note that the
replacement effect was not dose dependent since significant differences were not found
between the two replacement groups.
Evidence from the current study support the results o f an earlier, short-term
study showing decreased substance P immunoreactivity in lumbar DRG neurons after 21
days o f continuous estradiol replacement (Sarajari and Oblinger, 1995). Substance P is
involved in the mediation o f nociception and is characteristic o f small diameter axons
from correspondingly small DRG neurons. A reduction in PPT gene expression and
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consequent decrease in substance P peptide levels should increase nociceptive
thresholds, i.e. make the neurons less sensitive to painful stimuli. The results o f the
testing, in the current study, using Hargreaves’ method o f testing warm thermal
withdrawal latencies generally uphold this expectation.

Warm Thermal Plantar Withdrawal Latencies
The OVX rats that received replacement estrogen showed a tendency to be less
sensitive to noxious warm thermal stimuli as indicated by the time it took them to
withdraw their hindlimb after onset o f painful plantar stimulation. Although means for
the 10X replacement group were higher than means for the IX group, which, in turn,
were higher than the OVX group the differences between the means were not significant.
The lack o f statistically significant differences between treatment groups and the
untreated OVX group may be due to inherent limitations in the apparatus and its
measuring procedures. The phenomenon o f “spontaneous walk-offs”, which could occur
within seconds o f applying the stimulus are difficult to control for and as such, could not
be separated from actual stimulus-induced withdrawals. Behavior such as paw licking or
rapid jerks removing the foot from the heat source were often present as an indication of
a response to noxious warm thermal stimuli. Conversely, a low-latency walk-off time
with no apparent reaction to a noxious stimuli was suspicious as producing a false data
point, yet lacked clear objective reason to be discarded as false. This
accounted for a portion o f the standard deviation.

variability

Since a learning effect was

demonstrated, i.e. a quicker withdrawal response in all groups as the study progressed,
retests for suspicious data points were also not appropriate.
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A second issue must also be considered in the interpretation o f these data.
Although the Hargreaves’ device is referred to as a warm thermal testing apparatus, it is
somewhat o f a misnomer. It more appropriately measures withdrawal from noxious
warm stimuli. Kenshalo (1979) points out, in his review article, that psychophysical
testing, i.e. detecting the presence o f

a warm stimuli, discriminating temperature

changes in warm stimuli and measuring withdrawal times from a noxious warm stimuli all
have overlapping components but are distinctly different types o f discriminations. When
appropriate, controls separating motivational components are used, tests in humans show
that elderly females (compared to elderly males and younger males and females) have a
reduced ability to sense pain from warm thermal stimuli (Clark and Mehl, 1971).
During the period o f peak estrogen levels, the proestrous phase o f the normal rat
cycle, sensitivity to pain measured by thermal withdrawal (tailflick) was reported to be
greatest (Frye, 1992). Although the results o f the current study indicate a reduction in
sensitivity to noxious warm stimuli with long-term continuously replaced estrogen, one
must consider the potentially different impact o f estrogen titers that rise and fall within
days and an estrogen serum level that remains constant for a extended period. Indeed, in
normally cycling animals, trkA mRNA levels are highest at proestrous, the time o f peak
circulating estrogen (Sohrabji, et al., 1994). From the current data, one would expea
PPT mRNA levels to also be high at proestrous. If so, substance P levels would be
elevated in the DRGs and pain sensitivity should be heightened as shown by Frye (1992).
For some as yet unknown reason, long-term, constant estrogen levels decrease trkA and
PPT gene expression and thereby reduce sensitivity to noxious warm stimuli.
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The foot withdrawal tunes show a longer latency when each groups’ first day
data is compared to its own seven-day mean.

This apparently indicates a learning

phenomenon, namely warmth paired with pain yields foot withdrawal to warmth
discrimination. The role o f the hippocampus in learning and memory is widely accepted.
The role o f estrogen on hippocampus is now being investigated in many
laboratories(Klintsova, et al., 1995, Bettini, et al.,1992, Teyler, et al. 1980). Since the
reduction in times within groups was not significantly different, no effects o f estrogen on
learning are apparent in this study.

Effect o f Long-Term Estrogen Treatment on 68kD Neurofilament Gene Expression
Data from the current study show an estrogen-dependent increase in 68kD
neurofilament mRNA levels. This response to estrogen appears to involve all or nearly
all neurons. If only a subpopulation o f DRG neurons express the ER gene, the dramatic
effects o f estrogen on neurofilament gene expression in all or most DRG is more difficult
to explain.
The 56-day group analyzed for neurofilament gene expression showed highly
significant results while the data from the 90-day group was not as clear-cut.
Replacement groups, Groups I and II and 1 o f 2 subjects included in the OVX group
produced data equivalent to the 56-day study.
The other subject in the OVX group was clearly different and produced results which
were not significant. There are several possible explanations for this finding. It may be
an indication o f a reversal o f the 56-day results such as the biphasic responses reported
for estrogen’s effect on trkA mRNA levels in the forebrain (Gibbs, 1992). Another
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explanation may be that replacement estrogen responsiveness is innately variable.
Authors in two studies (Sohrabji et al., 1994; Kow and Pfaf£ 1973) make specific points
in their discussions concerning the unexpectedly large variability o f their measured
dependent variables as o f result o f the administration o f exogenous estrogen.

This

phenomenon was confirmed by a report at the recent, 1997 AFAR (American Federation
of Aging Researech) meeting concerning replacement estrogen in humans (Kowas,
personal communication). Either the very small subject number included in the OVX 90day group could not show significant differences given a moderate amount o f
intrasubject variability, not atypical to results o f other estrogen replacement experiments,
or, the dose-dependent upregulation o f neurofilament mRNA seen in the 56-day groups
is not a feature o f longer term treatment with the higher dose.

In the case o f the

acetycholinesterase-estrogen relationship in forebrain, the time-course o f a biphasic
response is shortened as estrogen doses are increased (Luine, 1985).
Based on the population o f the DRG neurons in which neurofilament was
upregulated, the current study found that estrogen working through its effect on NGF
receptors could not account for the dramatic increase in mRNA levels demonstrated.
Virtually all large neurons displayed a climactic increase in the amount o f neurofilament
mRNA present following long-term estrogen treatment. Since exogenous NGF only
restores neurofilament mRNA levels in NGF receptor-expressing neurons, predominantly
smaller cells following axotomy (Verge, et al., 1990), estrogen must be working through
a mechanism other than one associated with trkA gene expression.
Although it has been demonstrated that regulation o f neurofilament by NGF
molecules results in a coordinate upregulation o f all three neurofilament subunits genes
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in vitro (Lindebaum, 1988), neurofilament subunit gene expression may not always be
coordinately upregulated in vivo, as suggested by the work of Muma and colleagues
(1990).
Typically, however, in the adult DRG, neurofilament subunit gene expression is
coordinate and therefore, long-term estrogen treatment would be predicted to upregulate
the 1451cD and 200kD neurofilament genes.

If so, one would predict further that

treatment by estrogen would increase intermediate filament synthesis and assembly in
DRG neurons. This would increase sensory axon diameters and consequently improve
conduction velocities. This anticipated physiological correlate to estrogen treatment
could easily be tested if the necessary testing equipment becomes available to the
laboratory.

Use of Different Forms o f Estrogen
Caution must be taken when comparing research studies that used different forms
o f estrogen.

Premarin (Wyeth-Ayerst), which was the form o f estrogen used in the

current study, is a commercial formulation widely used in clinical estrogen replacement
therapy. It is from natural sources, namely pregnant mare urine (from which its name is
taken). It is composed o f a mixture o f conjugated estrogens. According to WyethAyerst, the manufacturer, it has five components. The major components are estrone,
equilin and 17 a-dihydroequilin. The minor components are 17 a-estradiol equilenin and
17 a-dihydroequilenin.

Washburn (1993) tested the components o f Premarin.

He

examined ten forms o f estrogen present in Premarin individually. This suggests that the
five components not listed by Wyeth-Ayerst are either in such minute quantities that
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reporting their presence in the formulation is not required or that the five additional
components tested by Washburn are breakdown metabolites o f the five listed
components.
According to Premarin’s manufacturer, Wyeth-Ayerst, estrogens are produced by
the ovaries, which make several kinds o f estrogens. They further state that all estrogens
have similar properties and therefore much the same usefulness, side effects and risks.
While this is true at this time, it does not say that there are “no differences”, only that
they have not been well investigated.

Two studies (Washburn, et al., 1993 and

Mermelstein, 1996) have looked specifically for and have found differences in the
relative effects o f the various forms o f estrogen in different estrogen-responsive tissues.
Differential effects o f the individual Premarin components may allow benefits o f
estrogen to be administered to women otherwise at risk for breast or endometrial
cancer. During the normal aging process, the composition o f the circulating estrogen
changes from predominantly estradiol to estrone (Erickson and Scheiber, 199S). This
might suggest that the collateral benefits o f estrogen to non-reproductive organs and
tissues are maintained more by estrone than by estradiol.
Is estrogen a nervous tissue growth factor and does it interact with growth
factors other than NGF? It is known that estrogen promotes the growth o f some tumors
in breast and endometrium and therefore, acts as a growth factor in these tissues. One
study has indicated a possible connection with insulin-like growth factor (IGF) in the
nervous system (Toran-Allerand et al, 1988). In that study, explants o f hypothalamus
and forebrain were used. The data from the study clearly suggested that estrogen may
act synergistically with growth factors other than NGF, such as IGF. This may be true
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for the DRG where neurons are known to be responsive to members o f the insulin gene
family.

Resolution o f Apparently Conflicting Results
How can results (Sohrabji, et al, 1994) demonstrating an upregulation in trkA in
the DRG after estrogen administration be reconciled with the results o f the current
study? The time course and dosage are apparently critical. Demonstration o f a biphasic
response to estrogen in the CNS first emerged with the the interaction of estrogen and
choline acetyl transferase (ChAT) in basal forebrain. N ot only was the measured effect
reversed after long-term exposure, but the time course o f this reversal

was dose

dependent (Liune, 1985).
The emerging story on the low affinity NGF receptor has given us additional
clues. Recent data examining the effect o f extended administration o f estrogen on p75 in
basal forebrain neurons parallels the findings in the current study. This study (Gibbs and
Pfaff, 1992) found that after two weeks o f estrogen replacement in rat the activity of
p75 was reversed compared to that found at earlier times .
A consistent story is emerging which seems to reconcile the apparently
contradictory results o f previous and current studies.

Firstly, trkA and p75 act

inversely at each group o f time points (short term vs. long term) and conversely from
short term to long term. Our report examined only trkA, but the combined data of
several labs now makes sense.
Short-term exogenous estrogen replacement (approximating the timing o f the
normal rat estrus cycle) as well as endogenous high levels o f estrogen (proestrous levels)
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in normally cycling rats result in an upregulation o f trkA and a downregulation o f p75 in
the basal forebrain and lumbar DRGs (Gibbs, 1992, Toran-Allerand, 1992 and Sohrabji,
1994).

In contrast, long term, continuous estrogen replacement results in a down

regulation o f trkA (Gibbs and Pfaf£ 1992) in forebrain and in DRG (current study) and
an upregulation o f p75 in forebrain (Gibbs, 1992).
An analysis o f known data concerning substance P, PPT and the resultant
response o f withdrawal to noxious warm stimuli follows logically. Over the short term
an upregulation o f trkA during proestrous would expectedly yield an upregulation of
substance P resulting in greater sensitivity to noxious warm stimuli (Frye, 1988) during
normal cycling. Conversely, over the long-term a down-regulation o f trkA would be
expected to yield a down-regulation o f substance P

in DRG (Sarajari and Oblinger,

1995) and PPT in DRG (current study) as well as diminished sensitivity to noxious
warm stimuli (current study).
The results show that the DRG cell populations containing ER, trkA and PPT
mRNAs are overlapping. Many small DRG neurons contain ER, PPT (substance P) and
trkA

In the current study neither the regulation o f PPT nor the regulation o f trkA

mRNA levels by estrogen was dose-dependent.
The cell population and the dynamics involving NGF and neurofilament
(Hoffinan, 1984, 1985, and 1987) and estrogen, NGF (receptor) and neurofilament in
this study are very different from the cell population and dynamics involved with NGF
(receptor) estrogen and PPT. Neurofilament mRNA levels after long-term (56-day)
estrogen replacement are increased and are dose dependent. Whether the time course is
merely different from that seen for PPT and trkA, and that an eventual down-regulation
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for neurofilament occurs with continuous replacement is uncertain. Although the mean
mRNA level for the 90-day 10X is much higher than that for either the IX or the OVX
group, the mean disguises the fact that the animals within this group reflect very
different means (variability) and hence the 10X group is not statistically different from
the IX group. Whether this reflects a deterioration o f the phenomenon observed at 56
days or not cannot be determined at this point.
Alterations in sensory function resulting from changes in estrogen levels are
largely unexplored. A few scattered papers indicate intriguing possibilities in several
sensory modalities. Hearing might be affected by estrogen.

ERs have been found

recently in the cochlear nucleus (Simeriy, 1990) and estrogen levels have been reported
to affect .

In the auditory system, one study (Coleman, et al., 1994) has reported

differences based on estrogen status. The results o f this study provide a significant and
positive result which has many ramifications and opens the possibilities for broadened
investigations on the effects o f estrogen on sensation. Finally, the hypothesis can be
raised, does estrogen affect sensation in males, and how do other hormones affect
sensation? It is entirely unknown whether males have estrogen receptors on sensory
cells. Whether or not parallel processes occur in males with different hormones is also
unknown.

What is known is that males convert testosterone to estrogen with the

enzyme aromatase in certain basal forebrain nuclei, i.e. a mechanism exists in the nervous
system o f males which makes testosterone conversion to estrogen a possibility. Also,
males show an increase in cutaneous receptive field after the administration o f exogenous
estrogen (Kow and PfafF, 1973).

Considering the highly homologous nature o f all
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steroid hormones and their receptors, it is not unlikely that some non-specific binding
may occur between hormones and their ligands.
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CONCLUSIONS
Traditionally, the effects o f estrogen in brain have been characterized as effects
associated with reproduction. The role o f the hypothalamus as a regulator o f the
reproductive cycle is well documented. Yet, perhaps it is our definition o f reproductive
behavior which needs to be re-examined. In the animal studies in which an increase in
skin sensitivity was shown to occur as a result o f estrogen, behavior indicating the
female’s acceptance o f the male can be identified as the probable link to reproduction.
Nesting behavior, a secondary reproductive function was documented in the canary
brood patch study. In the current Physicians Desk Reference’s review on Premarin, it
states that one o f the effects o f this hormone replacement is a dramatic increase in the
number o f reports o f sexual fantasy.

The possible number o f synapses which are

involved in this neural activity are imponderable, yet somehow occur as a result o f
estrogen replacement.

When we consider that the role o f sex is, o f course, directly

responsible for the survival o f the species, it makes sense that the molecule o f estrogen is
probably as old as sexual reproduction itself and that its role within each species has
evolved as well. What we define as sexual behavior may be broadened to include many
behaviors secondary to the reproductive cycle, per se.
During the normal process of aging the primary reproductive function for
females ceases. The point is, o f course, that the role o f estrogen in the normal aging
body has many overlapping functions with that o f secondary sexual and reproductive
behavior.

For example, skin sensitivity, which is important in mating and nesting

behavior, is important during all ages of one’s life.
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The somatosensory sensations include vibration sense, two-point touch
discrimination, pain and temperature as well as proprioception. These sensations make
use o f different subsets o f receptors and are subserved by different groups o f DRG
neurons.

The experiments in this paper have begun to sort out how long-term

continuous estrogen replacement affects these DRG neurons and the sensations which
they carry.
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Protocol for Riboprobc Synthesis

Dry down even aliquots o f 33P in speed-vac fo r30 minutes.
Set up 10 ul transcription rxns (n + 1 ):

X I
2 ul transcription buffer
I ul D T T
I ul Rnasin
0.5 ul rATP
0.5 ul rCTP
0.5 ul rGTP
1.5 ul sH 20

X.
_

Add 7 ul transcription rxn to dried down isotope and vortex.
Add 2 ul o f {2ug/ul} D N A template (sense and antisense o f each).
Add I ul o f appropriate polymerase enzyme to appropriate tube:
DCfA.

Polymerase Enzvme

A

Incubate tubes fo r 1 h o u r at 3 7 *C .
Tough rxn m ixture w ith m icrqtip and rinse in 5 ul o f DEPC H 2 0 . Spot 2 ul on chromotography strip and
allow to air dry. Place spotted end in IM K H 2P 04 and allow buffer to run to top o f strip.
A ir dry strip and expose to film fo r 30 minutes.
Stop transcription rxn by adding I ul Dnase to each tube and incubate fo r 15 m in at 37* C.

Add 30 ul DEPC H 2 0 to bring to final volume o f 40 ul per tube.
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Protocol for in situ Hybridization

Deparaffinate:

5
3
3
3
3

X ylene
100 % E T O H
95% E TO H
70% E TO H
50% ETO H

min
min
m in
m in
min

3X
2X
1X
IX
1X

PRE-H YB R ID IZA TIO N
1.

Incubate sections in 0 .0 2 M H C L 10 m in a t R T. (Partially solubilizes th e highly cross-linked acidic
nuclear proteins, enabling easier access to the probe.)
(300 ul H C L in 2 0 0 m is D E P C H 2 0 )

2.

W ash in 1X PB S 5 m in , 2 X
(20 ml 1 0 X P B S in 1 8 0 m l D E P C H 2 0 )

3.

W ash in 1 X PBS th a tis 0 .0 1 % T riton X -1 0 0 90
(20 ul in 2 0 0 m l 1 X P B S )

4.

Rinse b rie fly in D E P C H 2 0 .

5.

Treat w ith 2 X S S C a t 7 0 *C 30 m in .
(20 m l 2 0 X S S C in 18 0 m l D E P C H 2 0 )

6.

Proteinase K tre a t a t 3 7 *C 3 0 m in . (D e g rad es m any o f ttie cross-linked
proteins.)

sec.

(Loosens lipid m embrane proteins.)

(20 m l 1M T ris, 2 0 m l 0 .5 M E D T A in 1 6 0 m l DEPC H 2 0 . Add 1 0 0 -2 0 0 ul o f 1 0 m g /m l Proteinase K
just prior to adding slides.^ 7.

Rinse b rie fly in D E P C H 2 0 .

8.

fix in 4% fo rm ald eh yde o r p araform ald eh yd e, 1X PBS 10 m in. (H e lp s to p reven t loss of r ‘ "-ieic
add sequ ences during rem aining steps.)
(180 m l 4% form aldehyde plus 20 m l I X PBS)

9.

R inse b rie fly in 1 X PB S.

10.

Acetyl a te 10 m in w hile shaking 0 .1 M T E A w ith acetic anhydride added ju st b efo re slides.
(Reduces level o f endogenous alkalin e phosphatase in the tissue.)
(20 ml 1M T E A in 180 m l D E P C H 2 0 plus 50 0 ul acetic anhydride a d d e d ju s t prior to adding

slides.)
11 .

12.

R inse in 2 X S S C

1 m in .

Serially d ehydrate in E TO H :

70%
80%
95%
100%

1 -5 min
1 min
1 min
1 min
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